Cytokinetics, Incorporated (CYTK)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
Pre-market:
| Previous close | 67.93 |
| Open | 67.50 |
| Bid | 66.91 x 400 |
| Ask | 67.01 x 200 |
| Day's range | 66.84 - 68.53 |
| 52-week range | 25.98 - 110.25 |
| Volume | |
| Avg. volume | 2,086,909 |
| Market cap | 7.007B |
| Beta (5Y monthly) | 0.68 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- GuruFocus.com
EVP Research & Development Fady Malik Sells Shares of Cytokinetics Inc (CYTK)
Cytokinetics Inc (NASDAQ:CYTK), a biopharmaceutical company focused on the discovery and development of next-generation therapeutics for muscle diseases, has reported an insider sale according to a recent SEC filing.
- Insider Monkey
30 Biggest Biotechnology Companies in the World
In this article, we will be taking a look at the 30 biggest biotechnology companies in the world. If you do not want to learn about the global biotech market, head straight to the 5 Biggest Biotechnology Companies in the World. In the ever-evolving landscape of biotechnology, several companies like Novo Nordisk, Regeneron, and United […]
- Thomson Reuters StreetEvents
Q4 2023 CytomX Therapeutics Inc Earnings Call
Q4 2023 CytomX Therapeutics Inc Earnings Call
© 2024 Yahoo. All rights reserved.